| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2025―Mai―16 |
LL-37 Inhibits TMPRSS2-Mediated S2' Site Cleavage and SARS-CoV-2 Infection but Not Omicron Variants |
Zhenfei Bi, Wenyan Ren, Hao Zeng, Yuanyuan Zhou, Jian Liu, Zimin Chen, et al. (+5) Xindan Zhang, Xuemei He, Guangwen Lu, Yuquan Wei, Xiawei Wei |
| 2 |
[GO] |
2025―Jan―27 |
Airway Basal Stem Cells Inflammatory Alterations in COVID-19 and Mitigation by Mesenchymal Stem Cells |
Sheng Du, Jing Jin, Chunli Tang, Zhuquan Su, Lulin Wang, Xinyuan Chen, et al. (+6) Mengni Zhang, Yiping Zhu, Jiaojiao Wang, Chunrong Ju, Xinyu Song, Shiyue Li |
| 3 |
[GO] |
2024―Feb―26 |
Proteome analysis develops novel plasma proteins classifier in predicting the mortality of COVID-19 |
Yifei Zeng, Yufan Li, Wanying Zhang, Huidan Lu, Siyi Lin, Wenting Zhang, et al. (+4) Lexin Xia, Huiqun Hu, Yuanlin Song, Feng Xu |
| 4 |
[GO] |
2023―Okt―11 |
Integration of human organoids single-cell transcriptomic profiles and human genetics repurposes critical cell type-specific drug targets for severe COVID-19 |
Yunlong Ma, Yijun Zhou, Dingping Jiang, Wei Dai, Jingjing Li, Chunyu Deng, et al. (+11) Cheng Chen, Gongwei Zheng, Yaru Zhang, Fei Qiu, Haojun Sun, Shilai Xing, Haijun Han, Jia Qu, Nan Wu, Yinghao Yao, Jianzhong Su |
| 5 |
[GO] |
2023―Mrz―20 |
Post-hospitalization rehabilitation alleviates long-term immune repertoire alteration in COVID-19 convalescent patients |
Bing Feng, Danwen Zheng, Laijun Yang, Zuqing Su, Lipeng Tang, Ying Zhu, et al. (+19) Xiaohua Xu, Qian Wang, Qiaoli Lin, Jiajun Hu, Meixuan Lin, Liqun Huang, Xin Zhou, Han Liu, Song Li, Wenjing Pan, Rongdong Shi, Yanjing Lu, Bin Wu, Banghan Ding, Zhe Wang, Jianwen Guo, Zhongde Zhang, Guangjuan Zheng, Yuntao Liu |
| 6 |
[GO] |
2022―Feb―10 |
Cellular and molecular atlas of the placenta from a COVID-19 pregnant woman infected at midgestation highlights the defective impacts on foetal health |
Jingsi Chen, Lili Du, Feiyang Wang, Xuan Shao, Xiaoyi Wang, Wenzhe Yu, et al. (+23) Shilei Bi, Dexiong Chen, Xingfei Pan, Shanshan Zeng, Lijun Huang, Yingyu Liang, Yulian Li, Rufang Chen, Fengwu Xue, Xiuying Li, Shouping Wang, Manli Zhuang, Mingxing Liu, Lin Lin, Hao Yan, Fang He, Lin Yu, Qingping Jiang, Zhongtang Xiong, Lizi Zhang, Bin Cao, Yan-Ling Wang, Dunjin Chen |
| 7 |
[GO] |
2021―Jul―22 |
Molecular evidence suggesting the persistence of residual SARS-CoV-2 and immune responses in the placentas of pregnant patients recovered from COVID-19 |
Hao Wu, Shujie Liao, Yiming Wang, Ming Guo, Xingguang Lin, Jianli Wu, et al. (+18) Renjie Wang, Dan Lv, Di Wu, Mengzhou He, Bai Hu, Rui Long, Jing Peng, Hui Yang, Heng Yin, Xin Wang, Zhixiang Huang, Ke Lan, Yanbin Zhou, Wei Zhang, Zhenyu Xiao, Yun Zhao, Dongrui Deng, Hongmei Wang |
| 8 |
[GO] |
2021―Mrz―10 |
Bioinformatic analyses hinted at augmented T helper 17 cell differentiation and cytokine response as the central mechanism of COVID-19-associated Guillain-Barré syndrome |
Zheng Li, Ziheng Huang, Xingye Li, Cheng Huang, Jianxiong Shen, Shugang Li, et al. (+4) Lin Zhang, Sunny H. Wong, Matthew T. V. Chan, William Ka Kei Wu |
| 9 |
[GO] |
2020―Nov―20 |
Direct inhibitory effect on viral entry of influenza A and SARS-CoV-2 viruses by azithromycin |
Xiaohong Du, Xiangyang Zuo, Fang Meng, Chenfeng Han, Wei Ouyang, Yu Han, et al. (+4) Yayun Gu, Xin Zhao, Feng Xu, Frank Xiaofeng Qin |
| 10 |
[GO] |
2020―Nov―18 |
Safety and feasibility of umbilical cord mesenchymal stem cells in patients with COVID-19 pneumonia: A pilot study |
Ying Feng, Jianying Huang, Jianyuan Wu, Yan Xu, Bo Chen, Lijun Jiang, et al. (+3) Hui Xiang, Zhiyong Peng, Xinghuan Wang |
| 11 |
[GO] |
2020―Nov―03 |
Network pharmacology and molecular docking analyses on Lianhua Qingwen capsule indicate Akt1 is a potential target to treat and prevent COVID-19 |
Qi-Dong Xia, Yang Xun, Jun-Lin Lu, Yu-Chao Lu, Yuan-Yuan Yang, Peng Zhou, et al. (+3) Jia Hu, Cong Li, Shao-Gang Wang |
| 12 |
[GO] |
2020―Okt―27 |
First case of COVID-19 infused with hESC derived immunity- and matrix-regulatory cells |
Jun Wu, Zhongjie Hu, Liu Wang, Yuanqing Tan, Wei Hou, Zhongwen Li, et al. (+8) Tingting Gao, Jiaqi Fan, Baojie Guo, Huaping Dai, Wei Li, Jie Hao, Ronghua Jin, Baoyang Hu |
| 13 |
[GO] |
2020―Okt―27 |
Phase 1 trial for treatment of COVID-19 patients with pulmonary fibrosis using hESC-IMRCs |
Jun Wu, Xing Zhou, Yuanqing Tan, Liu Wang, Tianda Li, Zhongwen Li, et al. (+7) Tingting Gao, Jiaqi Fan, Baojie Guo, Wei Li, Jie Hao, Xianguang Wang, Baoyang Hu |
| 14 |
[GO] |
2020―Okt―24 |
Stem cell therapy for COVID-19, ARDS and pulmonary fibrosis |
Zhongwen Li, Shuaishuai Niu, Baojie Guo, Tingting Gao, Lei Wang, Yukai Wang, et al. (+4) Liu Wang, Yuanqing Tan, Jun Wu, Jie Hao |
| 15 |
[GO] |
2020―Okt―23 |
Single-cell analysis identified lung progenitor cells in COVID-19 patients |
Zixian Zhao, Yu Zhao, Yueqing Zhou, Xiaofan Wang, Ting Zhang, Wei Zuo |
| 16 |
[GO] |
2020―Okt―20 |
Organoid technology demonstrates effects of potential drugs for COVID-19 on the lung regeneration |
Jianhai Wang, Xue Li, An Wang, Fuxiaonan Zhao, Qi Wu, Li Li, et al. (+3) Hongzhi Yu, Junping Wu, Huaiyong Chen |
| 17 |
[GO] |
2020―Okt―20 |
Impaired lung regeneration after SARS-CoV-2 infection |
Hongxia Shao, Zhonghua Qin, Bei Geng, Junping Wu, Lixia Zhang, Qiuyang Zhang, et al. (+3) Qi Wu, Li Li, Huaiyong Chen |
| 18 |
[GO] |
2020―Okt―19 |
Detection of SARS-CoV-2 in saliva and characterization of oral symptoms in COVID-19 patients |
Lili Chen, Jiajia Zhao, Jinfeng Peng, Xiaoshuang Li, Xuliang Deng, Zhi Geng, et al. (+6) Zhenyu Shen, Fengyuan Guo, Qianwen Zhang, Yang Jin, Lin Wang, Songlin Wang |
|
